Dr. Royce Johnson has driven innovation with patented advancements in biomedical technology and
market positioning for three decades, with an emphasis on clinical systems and critical care
physiology. After a 30-year career of instigating medical technology nnovation from within industry, Dr.
Johnson is now applying his skills and creativity to a broader range of clients.
The focus of his work has evolved from early-stage technology incubation to addressing the front end of
innovation with a deep understanding of the customer. As he says, "the technology is the easy part."
Trained in biomedical engineering, technology management, and strategic innovation, he is an expert in
devising novel solutions to unrecognized opportunities across the clinical workplace domain.
During his 14-year tenure with therapeutic medical device developer KCI, Dr. Johnson advanced through
roles as principal scientist, manager/director of new technologies, director of innovation and ideation,
and corporate fellow for research. He is the first- or co-inventor of 17 issued U.S. patents, including
breakthrough developments revolutionizing wound therapy, tissue engineering, skin grafting,
phototherapy, and therapeutic hypothermia.
While with KCI, Dr. Johnson also led the creation and implementation of the entire front end of their
commercialization processes, from technology strategy to opportunity portfolio management. These
processes were based on the "outside-in" perspectives derived from his ethnographic demand studies
and they continue to generate numerous innovations for the firm. Doing more than studies, he ultimately
brought the outside-in home: he championed, designed, implemented, and directed the company's
acclaimed internal clinical simulation suite (complete with an OR, ICU, conference center, and support
spaces) as a core resource for in-context, hands-on education of both clinical customers and the
product commercialization teams.
Prior to joining KCI, Dr. Johnson spent his early career with Ohmeda, Inc. (now GE Healthcare) and
Baxter Healthcare as a project engineer and manager of advanced development/applied technologies.
Recognized twice by Frost & Sullivan as their "Most Valuable Thought Leader," Dr. Johnson teaches
these skills in workshops and as adjunct professor at several universities. He is the first- or co-inventor
of more than 20 issued, and numerous in-process, patents, including innovations in wound therapy,
tissue engineering, physiologic monitoring, and therapeutic hypothermia. Currently leading a program to
commercialize nanotechnology in healthcare markets, he has recently completed innovation projects in
corporate innovation process and breath analysis marketing.
Dr. Johnson earned his bachelor's, master's, and doctoral degrees in biology and bioengineering at the
University of Utah and holds a certificate in strategy and innovation from MIT Sloan School of
Management. Now independently practicing in strategic innovation, Dr. Johnson continues to pursue his
professional goal of applying and teaching the skills that enable large companies to innovate effectively.
"Royce is a passionate
innovator…He thinks beyond
traditional boundaries to uncover
potential opportunities hidden from
even the most technical minds…"
Chris Weyl, President,
"Royce's passion for innovation
coupled with his considerable
intellect allow him to engage across
a range of disciplines and traverse
across culture, technological, and
geographical boundaries in a quest
to find new and challenging ways to
innovate. He possesses a unique
Keith Heaton, Managing Director,
i2r Medical Ltd
"I worked with Royce to help shift the
innovation culture at KCI from being
product-centric to being user-centric.
Royce was a visionary…It's people
like Royce, with both critical thinking
and creative insight - and the humility
of an open mind! - that are needed to
drive and build truly innovative
Georgina Miller, Regional
Planning Director, DDB Hong